Home/Filings/4/0001387131-20-001553
4//SEC Filing

Blunt Roshawn A. 4

Accession 0001387131-20-001553

CIK 0000887247other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:21 PM ET

Size

5.8 KB

Accession

0001387131-20-001553

Insider Transaction Report

Form 4
Period: 2019-08-26
Transactions
  • Award

    Stock Appreciation Right

    2019-08-26+50,00050,000 total
    Exercise: $0.97Exp: 2026-08-26Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Each Stock Appreciation Right is the economic equivalent of one share of ADMP common stock and can only be settled in cash.
  • [F2]The Stock Appreciation Right ("SAR") will vest with respect to 8,333 shares subject to the SAR on the six-month anniversary of the date of grant, and thereafter 1,388 shares shall vest on each monthly anniversary of the date of grant with all remaining unvested shares subject to the SAR vesting on the thirty-sixth (36th) monthly anniversary of the date of grant.

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeother

Related Parties

1
  • filerCIK 0001787773

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:21 PM ET
Size
5.8 KB